371 210

Full metadata record

DC FieldValueLanguage
dc.contributor.author김찬형-
dc.date.accessioned2019-08-13T05:43:03Z-
dc.date.available2019-08-13T05:43:03Z-
dc.date.issued2019-03-
dc.identifier.citation방사선방어학회지, v. 44, NO 1, Page. 32-42en_US
dc.identifier.issn2508-1888-
dc.identifier.issn2466-2461-
dc.identifier.urihttp://jrpr.org/journal/view.php?doi=10.14407/jrpr.2019.44.1.32-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/108532-
dc.description.abstractBackground: There have been much efforts to develop the proper and realistic machine Quality Assurance (QA) reflecting on real Volumetric Modulated Arc Therapy (VMAT) plan. In this work we propose and test a special VMAT plan of plan-class specific (pcsr) QA, as a machine QA so that it might be a good solution to supplement weak point of present machine QA to make it more realistic for VMAT treatment. Materials and Methods: We divided human body into 5 treatment sites: brain, head and neck, chest, abdomen, and pelvis. One plan for each treatment site was selected from real VMAT cases and contours were mapped into the computational human phantom where the same plan as real VMAT plan was created and called plan-class specific reference (pcsr) QA plan. We delivered this pcsr QA plan on a daily basis over the full research period and tracked how much MLC movement and dosimetric error occurred in regular delivery. Several real patients under treatments were also tracked to test the usefulness of pcsr QA through comparisons between them. We used dynalog file viewer (DFV) and Dynalog file to analyze position and speed of individual MLC leaf. The gamma pass rate from portal dosimetry for different gamma criteria was analyzed to evaluate analyze dosimetric accuracy. Results and Discussion: The maxRMS of MLC position error for all plans were all within the tolerance limit of ˂ 0.35 cm and the positional variation of maxPEs for both pcsr and real plans were observed very stable over the research session. Daily variations of maxRMS of MLC speed error and gamma pass rate for real VMAT plans were observed very comparable to those in their pcsr plans in good acceptable fluctuation. Conclusion: We believe that the newly proposed pcsr QA would be useful and helpful to predict the mid-term quality of real VMAT treatment delivery.en_US
dc.description.sponsorshipThis work was supported by the Nuclear Safety Research Program through the Korea Foundation Of Nuclear Safety (KoFONS) using the financial resource granted by the Nucle-ar Safety and Security Commission (NSSC) of the Republic of Korea (No. 1705006).en_US
dc.language.isoenen_US
dc.publisher대한방사선방어학회en_US
dc.subjectVMATen_US
dc.subjectQuality Assuranceen_US
dc.subjectPlan-class specific referenceen_US
dc.subjectGamma pass rateen_US
dc.subjectMaxRMSen_US
dc.titlePlan-Class Specific Reference Quality Assurance for Volumetric Modulated Arc Therapyen_US
dc.typeArticleen_US
dc.relation.no1-
dc.relation.volume44-
dc.identifier.doi10.14407/jrpr.2019.44.1.32-
dc.relation.page32-42-
dc.relation.journal방사선방어학회지-
dc.contributor.googleauthorRahman, Mohammad Mahfujur-
dc.contributor.googleauthorKim, Chan Hyeong-
dc.contributor.googleauthorKim, Seonghoon-
dc.relation.code2019035086-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF ENGINEERING[S]-
dc.sector.departmentDEPARTMENT OF NUCLEAR ENGINEERING-
dc.identifier.pidchkim-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE